Letitia N Laurien, LCSW | |
2204 Executive Dr, Suite A, Hampton, VA 23666-6602 | |
(757) 644-3989 | |
(866) 813-7798 |
Full Name | Letitia N Laurien |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 2204 Executive Dr, Hampton, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013158963 | NPI | - | NPPES |
4945573 | Medicaid | VA |
Mailing Address | Practice Location Address |
---|---|
Letitia N Laurien, LCSW 1233 23rd St, Newport News, VA 23607-4801 Ph: (772) 678-1397 | Letitia N Laurien, LCSW 2204 Executive Dr, Suite A, Hampton, VA 23666-6602 Ph: (757) 644-3989 |
News Archive
ImmunoCellular Therapeutics announced today that the U.S. Food and Drug Administration has granted orphan drug designation for ICT-107, the company's dendritic cell-based cancer vaccine candidate which targets glioblastoma multiforme. As a result of the orphan drug status, ImmunoCellular will be eligible to receive a number of benefits, including access to grant funding for clinical trials, tax credits, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of up to seven years.
Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.
Teva Pharmaceutical Industries Ltd. announced today it is seeking to amend its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent infringement of three additional patents related to the characterization of COPAXONE® (glatiramer acetate injection). The proposed updated complaint has been filed under seal with the U.S. District Court for the Southern District of New York along with a motion requesting that the Court grant Teva leave to amend.
Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.
› Verified 1 days ago